These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21468600)

  • 1. Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with different lipid profiles.
    Yoshida T; Kato K; Oguri M; Horibe H; Kawamiya T; Yokoi K; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Yamada Y
    Mol Med Rep; 2011; 4(3):511-8. PubMed ID: 21468600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus or chronic kidney disease.
    Yoshida T; Kato K; Oguri M; Horibe H; Kawamiya T; Yokoi K; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Yamada Y
    Int J Mol Med; 2011 May; 27(5):745-52. PubMed ID: 21347509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic variants with myocardial infarction in Japanese individuals with different lipid profiles.
    Yoshida T; Kato K; Yokoi K; Oguri M; Watanabe S; Metoki N; Yoshida H; Satoh K; Aoyagi Y; Nozawa Y; Yamada Y
    Int J Mol Med; 2010 Apr; 25(4):607-16. PubMed ID: 20198310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
    Yoshida T; Kato K; Horibe H; Oguri M; Fukuda M; Satoh K; Aoyagi Y; Shinkai S; Nozawa Y; Yamada Y
    Nephrology (Carlton); 2011 Sep; 16(7):642-8. PubMed ID: 21557786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.
    Yamada Y; Nishida T; Ichihara S; Sawabe M; Fuku N; Nishigaki Y; Aoyagi Y; Tanaka M; Fujiwara Y; Yoshida H; Shinkai S; Satoh K; Kato K; Fujimaki T; Yokoi K; Oguri M; Yoshida T; Watanabe S; Nozawa Y; Hasegawa A; Kojima T; Han BG; Ahn Y; Lee M; Shin DJ; Lee JH; Jang Y
    Atherosclerosis; 2011 Mar; 215(1):145-52. PubMed ID: 21211798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals.
    Horibe H; Ueyama C; Fujimaki T; Oguri M; Kato K; Ichihara S; Yamada Y
    Mol Med Rep; 2014 Mar; 9(3):808-12. PubMed ID: 24452779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.
    Yoshida T; Yajima K; Hibino T; Kato K; Matsuo H; Segawa T; Watanabe S; Oguri M; Yokoi K; Nozawa Y; Kimura G; Yamada Y
    Int J Mol Med; 2007 Oct; 20(4):581-90. PubMed ID: 17786291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.
    Yamada Y; Matsui K; Takeuchi I; Fujimaki T
    Int J Mol Med; 2015 May; 35(5):1290-300. PubMed ID: 25813695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
    Hiramatsu M; Oguri M; Kato K; Yoshida T; Fujimaki T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Murohara T; Yamada Y
    Diabet Med; 2011 Nov; 28(11):1381-7. PubMed ID: 21672009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals.
    Horibe H; Kato K; Oguri M; Yoshida T; Fujimaki T; Kawamiya T; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Murohara T; Yamada Y
    Am J Hypertens; 2011 Aug; 24(8):924-9. PubMed ID: 21525964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations.
    Oguri M; Kato K; Yoshida T; Fujimaki T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Shin DJ; Lee JH; Jang Y; Yamada Y
    J Med Genet; 2011 Nov; 48(11):787-92. PubMed ID: 21784758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations.
    Fujimaki T; Kato K; Oguri M; Yohida T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Shin DJ; Lee JH; Jang Y; Yamada Y
    Exp Ther Med; 2011 Jul; 2(4):745-749. PubMed ID: 22977569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
    Yoshida T; Kato K; Yokoi K; Oguri M; Watanabe S; Metoki N; Yoshida H; Satoh K; Aoyagi Y; Nishigaki Y; Nozawa Y; Yamada Y
    Int J Mol Med; 2009 Aug; 24(2):233-46. PubMed ID: 19578796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction.
    Sigdel M; Yadav BK; Gyawali P; Regmi P; Baral S; Regmi SR; Jha B
    BMC Res Notes; 2012 Nov; 5():640. PubMed ID: 23158803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese.
    Shioji K; Mannami T; Kokubo Y; Goto Y; Nonogi H; Iwai N
    J Hum Genet; 2004; 49(8):433-439. PubMed ID: 15258834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.
    Pikula A; Beiser AS; Wang J; Himali JJ; Kelly-Hayes M; Kase CS; Yang Q; Seshadri S; Wolf PA
    Neurology; 2015 Feb; 84(5):472-9. PubMed ID: 25568296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mildly Abnormal Lipid Levels, but Not High Lipid Variability, Are Associated With Increased Risk of Myocardial Infarction and Stroke in "Statin-Naive" Young Population A Nationwide Cohort Study.
    Park JB; Kim DH; Lee H; Hwang IC; Yoon YE; Park HE; Choi SY; Kim YJ; Cho GY; Han K; Kim HK
    Circ Res; 2020 Mar; 126(7):824-835. PubMed ID: 31978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
    Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.